A naphthoquinone derivative, ␤-lapachone (␤L; 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione), is receiving huge attention for its potent therapeutic effects against various diseases. However, during the preclinical safety evaluation, repeated oral treatment of ␤L in rats induced anemia, i.e., a significantly decreased erythrocyte count. In this study, in an effort to elucidate the mechanism underlying the ␤L-induced anemia, we investigated the effects of ␤L on erythrocytes with freshly isolated human erythrocytes in vitro and rat in vivo. ␤L did not induce erythrocyte hemolysis, indicating that direct hemotoxicity was not involved in ␤L-associated anemia. Meanwhile, phosphatidylserine (PS) exposure along with spherocytic shape change and microvesicle generation, important factors in the facilitation of erythrophagocytosis, were increased significantly by ␤L. The PS exposure on erythrocytes was from ␤L-induced reactive oxygen species generation and subsequent depletion of reduced glutathione and protein thiol, which culminated in the modified activities of phospholipid translocases, i.e., inhibition of flippase and activation of scramblase. It is important to note that coincubation of macrophage with ␤L-treated erythrocyte in vitro showed increased erythrophagocytosis, demonstrating that the removal of erythrocyte by macrophage can be facilitated by ␤L-induced PS exposure. In good accordance with these in vitro results, after oral administration of ␤L in rats, increased PS exposure and depletion of glutathione were observed along with enhanced splenic sequestration of erythrocytes. In conclusion, these results suggest that ␤L-induced anemia might be mediated through the PS exposure and subsequent erythrophagocytosis, providing novel insight into the drug-induced anemia.
A naturally occurring naphthoquinone, ␤-lapachone (␤L; 3,4-dihydro-2,2-dimethyl-2H-naphthol [1,2-b] pyran-5,6-dione) from the lapacho (Tabebuia avellanedae) tree is known to have various pharmacological activities, including antiviral, antiprotozoal, and anticancer effects (Dong et al., 2009; Menna-Barreto et al., 2009; Trachootham et al., 2009 ). These biological activities of ␤L were suggested to be from the inhibition of DNA topoisomerase activity or the impairment of DNA repair through reactive oxygen species (ROS) generation via NAD(P)H:quinine oxidoreductase 1 (Reinicke et al., 2005; Bey et al., 2007) . Reduction of ␤L by NAD(P)H:quinine oxidoreductase 1 generates unstable hydroquinone and ROS, inducing cytotoxicity against tumor cells through sulfhydryl-mediated reaction and nonspecific enzyme inhibition (Oliveira-Brett et al., 2002) . Incidentally, it is well known that ROS generation and sulfhydryl modification can induce cytotoxicity and tissue injuries, but few studies have been focused on the potential toxicity of ␤L.
Recently, antiobesity and antidiabetic effects of ␤L have been newly discovered Kim et al., 2009) , and preclinical development of ␤L as a new drug candidate has been initiated. However, during a routine repeat dose-toxicity study, a significant reduction in erythrocyte count, anemia, was observed in the rats treated with ␤L, raising a concern over its toxicity against erythrocytes. There was no obvious indication of bone marrow toxicity or other nonspecific toxicity in the general histopathology or blood biochemistry examination, signifying that a more complicated and specific mechanism might be involved in the ␤L-induced anemia.
Because of the frequent exposure to oxygen-rich environment, erythrocytes often become an easy target for ROS (Banerjee and Kuypers, 2004) and ROS-generating drugs (Beutler, 1969) , especially in individuals with decreased glutathione (GSH) levels resulting from the genetic glucose-6-phosphate dehydrogenase deficiency (Fanello et al., 2008) , chemotherapy, or other pathophysiological conditions. Depletion of cellular GSH and protein thiol makes erythrocytes more susceptible to ROS, causing various abnormal conditions, including hemolysis (Beutler, 1969) , shape change (Lucantoni et al., 2006) , and phosphatidylserine (PS) exposure (Banerjee and Kuypers, 2004) . Damaged erythrocytes are engulfed and destroyed by tissue macrophages of spleen and liver, a process called erythrophagocytosis, inducing severe anemia as observed in sickle cell anemia or other disease states (Kuypers et al., 1998; de Jong et al., 2001; Lang et al., 2007) .
PS exposure, an apoptotic marker on the cell surface is considered as a key signal to tissue macrophages for erythrophagocytosis (Kobayashi et al., 2007; Mercer and Helenius, 2008) . The PS exposure on erythrocytes can be induced by intracellular calcium increase and the depletion of ATP and thiol-regulated modification of phospholipid translocase activity (Banerjee and Kuypers, 2004; de Jong and Kuypers, 2006; Barber et al., 2009) . PS-exposing erythrocytes frequently accompany apoptotic features such as spherocytic shape change and PS-bearing microvesicle (MV) generation. More importantly, through the various PS receptors or PS binding glycoprotein on tissue macrophages, PS-exposing erythrocytes could be recognized and subsequently removed by tissue macrophages through erythrophagocytosis (Zhou, 2007; Dasgupta et al., 2008 ).
In the current study, we discovered that ␤L could induce PS exposure and MV generation without hemolysis in human and rat erythrocytes. It is important to note that ␤L-treated erythrocytes were easily removed by macrophages through erythrophagocytosis. Its underlying mechanism was elucidated, and the relevance of its finding to in vivo was examined in a repeat dose study with rats in an effort to provide novel insight into the role of PS exposure in drug-induced anemia.
Materials and Methods

Materials
␤L was chemically synthesized by Mazence Inc. (Suwon, Korea). 1-Palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproyl]-sn-glycero-3-phosphoserine and 1-oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-glycero-3-phosphocholine were purchased from Avanti Polar Lipids (Alabaster, AL). Glutaraldehyde solution, osmium tetroxide, purified human thrombin, calcium ionophore A23187, bovine serum albumin (BSA), HEPES, sodium citrate, SDS, dimethyl sulfoxide (DMSO), trichloroacetic acid, Tris-base, Tris-acetate, ATP bioluminescent assay kit, mercury orange, luminol, 5,5Ј-dithiobis(2-nitrobenzoic acid) (DTNB), L-ascorbic acid, Trolox, and nuclear fast red solution were obtained from Sigma-Aldrich (St. Louis, MO). Phycoerythrin-labeled monoclonal antibody against human glycophorin A (antiglycophorin A-retinal pigment epithelium) was from Denmark A/S (Glostrup, Denmark) and fluo-4 acetoxymethyl ester was from Invitrogen (Carlsbad, CA). Fluorescein-isothiocyanate (FITC)-labeled annexin V (annexin V-FITC) was from BD Pharmingen (San Diego, CA), and potassium ferrocyanide was from Samchun (Seoul, Korea). 2Ј,7Ј-Dichlorofluorescein diacetate (DCFH-DA) and 5-(and-6)-carboxyfluorescein diacetate (CFDA) were obtained from Invitrogen. Dulbecco's modified eagle medium (DMEM), Dulbecco's phosphate-buffered saline, penicillin/streptomycin, and fetal bovine serum were purchased from Invitrogen.
Preparation of Erythrocytes
With an approval from the Ethics Committee of Health Service Center at Seoul National University (Seoul, Korea), human blood was obtained from healthy male donors (18 -25 years old) using a Vacutainer with acid citrate dextrose and a 21-gauge needle (BD Biosciences, Franklin Lakes, NJ) on the day of each experiment. Preparation of erythrocytes was conducted according to the method described previously by Chung et al. (2007) , with minor modification. In brief, packed erythrocytes were washed three times with phosphate-buffered saline and once with Ringer's solution (125 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 32 mM HEPES, and 5 mM glucose, pH 7.4). Washed erythrocytes were resuspended in Ringer's solution to a cell concentration of 5 ϫ 10 7 cells/ml, and final CaCl 2 concentration was adjusted to 1 mM before use.
Flow Cytometric Analysis of Phosphatidylserine Exposure and Microvesicle Generation
After erythrocytes were treated with DMSO (vehicle) or ␤L for 24 h at 37°C, aliquots of blood samples were diluted 10-fold with Annexin binding buffer (125 mM NaCl and 10 mM HEPES, pH 7.4) and further incubated with the following substances for 30 min at room temperature in the dark. Annexin V-FITC was used as a marker for PS, whereas anti-glycophorin A-retinal pigment epithelium was used as an identifier of erythrocytes and erythrocytederived MVs. Negative controls for annexin V binding were stained with annexin V-FITC in the presence of EDTA instead of CaCl 2 adjusted to a final concentration of 2.5 mM. The MVs from erythrocytes had diameters less than 1 m compared with the 1-m-diameter standard beads in the histogram. Samples were analyzed with an FACSCalibur flow cytometer (BD Biosciences, San Jose, CA) equipped with argon-ion laser emitting at 488 nm. The light scatter and fluorescence channels were set on log scale. Data from 10,000 events were collected and analyzed using CellQuest Pro software (BD Biosciences). The extent of hemolysis was determined spectrophotometrically at 540 nm.
Microscopic Observation Using Scanning Electron Microscopy and Measurement of ROS
Erythrocytes were observed on scanning electron microscope (JEOL, Tokyo, Japan) according to the methods described previously by Chung et al. (2007) . ROS generation was determined by chemiluminescence and dichlorofluorescein (DCF) fluorescence. For chemiluminescence, luminol (250 M) was added to erythrocytes, and the reaction was initiated by adding ␤L. Chemiluminescence was monitored continuously up to 240 min using a luminometer (Auto Lumat LB953; Berthold Technologies, Bad Wildbad, Germany). The total amount of chemiluminescence was calculated by integrating the area under the curve. ROS-induced DCF fluorescence was measured using the fluorescent probe DCFH-DA according to the previously described method (Amer et al., 2004) . In brief, erythrocytes were preincubated at 37°C with 0.4 mM DCFH-DA for 15 min with horizontal agitation. After unloaded DCFH-DA was removed by washing with 1 mM CaCl 2 containing Ringer's solution, ␤L was treated for a further 240 min. The aliquots were diluted appropriately, and the fluorescence of intracellular DCF was measured with an FACSCalibur flow cytometer (BD Biosciences). jpet.aspetjournals.org erythrocytes were washed and incubated at 37°C for 3 min, with 40 M mercury orange. Cells were diluted in Ringer's solution and analyzed with an FACSCalibur flow cytometer (BD Biosciences).
Measurement of GSH and Protein Thiol Levels
Protein thiol concentrations were measured by a modified assay based on a previously described colorimetric method (Di Monte et al., 1984) . One milliliter of ␤L-treated erythrocytes was centrifuged at 7000g for 1 min, and the pellet was resuspended with lysis buffer (5 mM sodium phosphate, pH 8.0) and incubated on ice for 30 min. Total lysate was resuspended with 5% perchloric acid in a ratio of 2:5 and then centrifuged at 7000g for 2 min. The pellet was solubilized in 1 ml of Tris-EDTA buffer (0.5 mM Tris-HCl and 5 mM EDTA, pH 7.6) containing 1% SDS. DTNB (250 M) was added to the samples, and the change of the absorbance was measured at 412 nm. The content of protein thiol was calculated on the basis of a glutathione calibration curve and divided by the protein content, which was measured by protein assay kit (Bio-Rad Laboratories, Hercules, CA).
Measurement of Phospholipid Translocation
Phospholipid translocation was measured according to the methods described previously (Hilarius et al., 2004) . In brief, erythrocytes (5 ϫ 10 7 cells/ml) were incubated with ␤L and then loaded with 0.
Aliquots from the cell suspension were removed at the indicated time intervals and placed on ice-cold Ringer's solution for 10 min in the presence or absence of 1% BSA. The amount of internalized probe was determined by comparing the fluorescence intensity associated with the cells before and after back-extraction. Samples were analyzed with an FACSCalibur flow cytometer (BD Biosciences).
Measurement of Intracellular ATP and Calcium Level
The measurement of ATP and calcium levels was simply modified from the methods described previously by Chung et al. (2007) . Samples for detection of intracellular ATP level were adapted to luciferin/ luciferase assay in a Luminoskan microplate luminometer (Thermo Fisher Scientific, Waltham, MA) using an ATP assay kit (SigmaAldrich). For detecting intracellular calcium increase, erythrocytes were loaded with 3 M fluo-4 acetoxymethyl ester for 1 h at 37°C in the dark. After ␤L was incubated for indicated time, samples were analyzed with a FACSCalibur flow cytometer (BD Biosciences).
Measurement of in Vitro Erythrophagocytosis
Mouse macrophage cell line RAW 264.7 cells were purchased from American Type Culture Collection (Manassas, VA) and maintained in DMEM supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin/streptomycin at 37°C under 5% CO 2 atmosphere. RAW 264.7 cells were seeded (1 ϫ 10 6 cells/well) to a six-well plate for 24 h, followed by coincubation for 18 h with 200 l of vehicle-or ␤L-treated rat erythrocytes (2 ϫ 10 7 cells/well) and then observed with phase-contrast microscopy (model IX70; Olympus, Tokyo, Japan). Chemical treated erythrocytes were washed and resuspended with DMEM and then cocultured with macrophages at 37°C under 5% CO 2 atmosphere. For flow cytometric analysis, chemically treated erythrocytes were loaded with 10 M CFDA for 30 min before coincubation. After the coincubation, macrophages were harvested and washed for several times to remove unbound erythrocytes. Samples were analyzed with an FACSCalibur flow cytometer (BD Biosciences). Data from 50,000 events were collected and analyzed using CellQuest Pro software (BD Biosciences).
In Vivo Experiments
Detection of PS Exposure after ␤L Administration in Rats. All of the protocols used in vivo experiments were approved by the Ethics Committee of Animal Service Centre at Seoul National University. Male Sprague-Dawley rats (Samtako Co., Osan, Korea) weighing 200 to 250 g were used in all experiments. Before the experiments, animals were acclimated for 1 week. Food and water were provided ad libitum. At the time of experiment, rats were randomly grouped for control (saline, containing 1% sodium lauryl sulfate), 25, 75, and 200 mg/kg ␤L doses. Four hours after ␤L was administered per mouth, blood was collected from the abdominal aorta using 3.8% trisodium citrate as anticoagulant. An aliquot of blood sample was diluted 200-fold with the following buffer (10 mM HEPES-Na, 136 mM NaCl, 2.7 mM KCl, 2.0 mM MgCl 2 , 1.0 mM NaH 2 PO 4 , 5.0 mM dextrose, 5 mg/ml BSA, and 2.5 mM CaCl 2 , pH 7.4) and was stained with annexin V-FITC for 15 min in the dark. PS exposure was measured as described above.
Hematoxylin and Eosin Staining and Prussian Blue Staining of Organs. Liver and spleen were obtained surgically after blood collection, weighed, and fixed with 10% formalin. The tissue specimens were cut into 4-m-thick sections and stained with hematoxylin and eosin and ferrocyanide. After counterstaining with nuclear fast red solution, the ferrocyanide-stained slides were dehydrated and mounted. The slides were observed with bright-field microscope (CX41; Olympus).
Statistical Analysis
The means and standard errors of means were calculated for all treatment groups. The data were subjected to one-way analysis of variance followed by Duncan's multiple range test or Student's t test to determine which means were significantly different from the control. In all cases, a p value of Ͻ0.05 was used to determine significant differences.
Results
During the preclinical development, a significant reduction in erythrocyte counts was observed in the rats treated with ␤L for 2 weeks (Fig. 1A) . However, in freshly isolated human erythrocytes, even the high concentration of ␤L did not induce direct hemolysis (Fig. 1B) . In contrast, PS exposure, an important pathological change of erythrocytes, was significantly enhanced by ␤L treatment in concentration-and timedependent manners (Fig. 1, C and D) .
Along with the PS exposure, ␤L caused the release of erythrocyte membrane-derived MVs in concentration-and time-dependent manners (Fig. 2, A-C) . In line with the MV generation, ␤L-treated erythrocytes displayed echinocytes (Fig. 2D, arrow) , cells with protruded surface, and MV-shed spherocytes (Fig. 2D, arrowhead) , whereas vehicle-treated erythrocytes showed a normal discocytes. As shown in Fig.  2E , most of ␤L-generated MVs (99%) also expressed PS on their surfaces, which can be also engulfed by macrophages (Willekens et al., 2005) .
␤L-induced cytotoxicity is mainly mediated by oxidative stress through ROS generation (Reinicke et al., 2005) . To investigate whether ROS can be induced by ␤L, erythrocytes were incubated with ␤L and ROS was measured by DCF fluorescence and luminol-enhanced chemiluminescence. As shown in Fig. 3, A and B, ␤L increased ROS generation in a concentration-dependent manner. In accordance with the ROS generation, ␤L caused the depletion of GSH (Fig. 3C ) and protein thiol (Fig. 3D) , which is critical in the maintenance of cellular homeostasis when cells are exposed to the oxidative stress. To clarify the role of cellular ROS and protein thiol in ␤L-induced erythrocyte PS exposure, antioxidants and thiol donor were pretreated and PS exposure was measured. Both antioxidants and thiol donor could reverse ␤L-induced PS exposure (Fig. 3E) , suggesting that the thiol depletion from ␤L-induced ROS generation play an important role in the disturbance of PS asymmetry.
The depletion of intracellular protein thiol can activate scramblase and inhibit flippase that induces and maintains PS on the outer membrane, respectively (Tyurina et al., 2007) . Consistently, after ␤L treatment, the scramblase was activated, as measured by increased inward translocation of C 6 -NBD PC (Fig. 4A) , and the activity of flippase was inhibited as determined by decreased inward translocation of C 6 -NBD PS (Fig. 4B) . In addition to the depletion of protein thiol, flippase can also be affected by the depletion of intracellular ATP. As a result, ␤L was shown to induce ATP depletion in a concentration-dependent manner (Fig.  4C) . It is interesting to note that intracellular calcium level, another important mediator of scramblase activation and flippase inhibition, was not increased in ␤L-treated erythrocytes (Fig. 4D) .
PS exposure on erythrocytes can be a signal for the recognition and subsequent erythrophagocytosis by tissue macrophages. First, we confirmed that the ␤L-induced PS exposure was similar in rat erythrocytes to human erythrocytes (data not shown). To investigate the erythrophagocytosis, ␤L-exposed rat erythrocytes were coincubated with murine macrophage cell line RAW 264.7 cells for 18 h. As shown in Fig. 5A,   Fig. 1 . PS exposure by ␤L in human erythrocytes. A, ␤L was administered to Sprague-Dawley rats once daily for 2 weeks by mouth and blood cell counts (RBC, red blood cells; HCT, hematocrit) were measured. After human erythrocyte suspension was incubated with DMSO (vehicle control) or 10, 25, and 50 M ␤L for 24 h at 37°C, released hemoglobin due to hemolysis was measured (B) and flow cytometric analysis was conducted (C). Mercury chloride (5 M) was used as a positive control for hemolysis. With representative histograms of erythrocyte suspension treated with DMSO or 50 M ␤L, the percentages of cells expressing PS by dose dependence (C, inset) and time dependence (D) are shown. FL-1, fluorescence parameter-1 (FITC). Values are mean Ϯ S.E.M. of four to five independent experiments from different blood donors. ‫,ء‬ p Ͻ 0.05, significant differences from control group. Fig. 2 . Effects of ␤L on MV generation in human erythrocytes. After erythrocytes were treated with DMSO or 10, 25, and 50 M ␤L for 24 h at 37°C, the extent of MV generation was measured by flow cytometry. A, erythrocytes and MVs were identified by forward scatter characteristics in a representative dot plot. SSC-H, side scatter height; FSC-H, forward scatter height. B and C, dose-and time-dependent MV release from erythrocytes were measured. Values are mean Ϯ S.E.M. of four to five independent experiments from different blood donors. ‫,ء‬ p Ͻ 0.05, significant differences from control group. RBC, red blood cells. D, after treatment, the cells were fixed and the morphological changes were examined using scanning electron microscope. Representative data of three independent experiments from different blood donors was shown here (scale bar, 5 m). E, histogram of PS exposure on MVs generated by ␤L was represented using FITC-labeled annexin V. FL-1, fluorescence parameter-1 (FITC) Quinone-Induced Anemia through PS Exposure 417 ␤L-exposed erythrocytes were bound and engulfed by macrophages. The erythrophagocytosis by ␤L was further confirmed by significantly increased fluorescent macrophages resulting from phagocytosis of CFDA-loaded erythrocytes (Fig. 5B) , which was in a good correlation with ␤L-induced PS exposure (Fig. 1C) .
The effects of ␤L on PS exposure and splenic sequestration were examined in rats in vivo. Four hours after the oral administration of 0, 75, or 200 mg/kg ␤L (5 ml/kg), blood samples were collected to determine PS exposure and GSH levels on erythrocytes. ␤L indeed induced PS exposure and GSH depletion in vivo (Fig. 6A) , whereas erythrocyte integrity, as assessed by osmotic fragility-induced hemolysis was not affected (data not shown), in a good accordance with in vitro data. To explore the long-term consequences of the ␤L-induced erythrocyte PS exposure, rats were administered with ␤L once daily for 2 weeks; the time when anemia was Fig. 3 . Effects of ␤L on ROS generation and depletion of GSH and protein thiol in human erythrocytes. After erythrocytes were incubated with various doses of ␤L for 4 h, ROS generation was measured by flow cytometric analysis of DCF fluorescence (A) and luminol-enhanced chemiluminescence (B). C, intracellular GSH level was detected by flow cytometric analysis of intracellular GSH-bound mercury orange. D, after erythrocytes were incubated with ␤L for 24 h, protein thiol content in erythrocytes was measured by a colorimetric method using DTNB. E, effects of various inhibitors on PS exposure were determined with 100 M Trolox, 50 M vitamin C (Vit. C), and 1 mM dithiothreitol (DTT) for 15-min treatment before 50 M ␤L for 16 h. Values are mean Ϯ S.E.M. of three to four independent experiments from different blood donors. ‫,ء‬ p Ͻ 0.05, significant differences from control group; #, significant differences from ␤L alone group. Fig. 4 . Effects of ␤L on phospholipid translocation and intracellular ATP and calcium levels in human erythrocytes. Erythrocytes were treated with various doses of ␤L for 24 h at 37°C, and then the extent of phospholipid translocation was measured. A, activated C 6 -NBD PC translocation by scramblase was determined in ␤L-treated erythrocytes. B, inhibited C 6 -NBD PS translocation by flippase was measured as described under Materials and Methods. C, levels of intracellular ATP were measured by luciferin-luciferase assay. D, erythrocytes loaded with fluo-4 were treated with DMSO (control) or ␤L for 24 h, intracellular calcium levels were evaluated by fluorescent cells using flow cytometer. Values are mean Ϯ S.E.M. of three independent experiments. ‫,ء‬ p Ͻ 0.05, significant differences from control group. observed. The relative organ weights of both liver and spleen were increased significantly (Fig. 6B, top) , and more importantly, the spleen of ␤L-treated rats was accumulated with iron as determined by increased blue-staining with Prussian blue (Fig. 6B, bottom) , suggesting that ␤L accelerated erythrocyte clearance indeed through erythrophagocytosis.
Discussion
In the present study, we demonstrated that ␤L could induce anemia indirectly by enhancing erythrophagocytosis and subsequent splenic sequestration of erythrocytes through PS exposure without direct cytotoxicity on erythrocytes. ␤L-enhanced PS exposure was accomplished from the activation of scramblase and the inhibition of flippase by ROS generation and the depletion of GSH and protein thiol. The ␤L-treated erythrocytes also displayed abnormal shape and MV generation, which could further contribute to the erythrophagocytosis by tissue macrophages. These in vitro observations were confirmed in rat in vivo as determined by increased splenic sequestrations of erythrocytes in ␤L-treated rats. This is the first study showing that drug-induced PS exposure in erythrocytes can induce increased erythrocyte clearance and ultimately anemia, to our best knowledge.
␤L and its derivatives are receiving huge interest for potent therapeutic activities in various diseases, including cancer, obesity, and cardiovascular diseases (Dong et al., 2009; Hwang et al., 2009; Kim et al., 2009) . Notably, ROS generating capability is suggested as a key mode of action for both therapeutic and adverse effects of ␤L (Reinicke et al., 2005; Bey et al., 2007) . Considering the vulnerability of erythrocytes to oxidative stress, toxicity of ␤L to erythrocytes could be easily foreseeable. The recent finding of Miao et al. (2008) that a ␤L derivative could be rapidly sequestered into and metabolized in erythrocytes further supports the specific and selective toxicities of ␤L to erythrocyte. Besides ␤L, many ROS-generating drugs are being developed or marketed for therapeutic uses in cancer and other diseases (Davis et al., 2001; Fibach and Rachmilewitz, 2008; Trachootham et al., 2009 ). In conjunction with our findings with ␤L, we suggest that serious attention should be paid for the potential toxicity of the ROS-generating drugs to erythrocytes.
The maintenance of GSH level is vital for the protection of erythrocytes from ROS. Exemplifying this, in glucose-6-phosphate dehydrogenase deficiencies where sufficient NADPH is not provided for the maintenance of reduced GSH, erythrocytes were vulnerable to oxidative hemolysis by ROS-generating drugs, such as glibenclamide, doxorubicin, dapsone, and so on (Mason et al., 2007; Ganesan et al., 2009 ). Excessive ROS and resultant depletion of GSH could alter the activities of vital enzymes or proteins that need reduced cysteine residue and free thiol for their activity (Devaux, 1988; de Jong and Kuypers, 2006) , bringing about erythrocyte damages. In the present study, we demonstrated that ␤L-induced ROS could inhibit flippase and activate scramblase, perturbing the membrane phospholipid asymmetry and inducing PS exposure.
PS exposure is a key signal for the erythrocyte clearance by tissue macrophages (Mandal et al., 2005; Tyurina et al., 2007; Fairn and Grinstein, 2008) and novel PS receptors on splenic macrophages are being identified such as Tim4 (T-cell immunoglobulin-and mucin domain-containing molecule) (Kobayashi et al., 2007; Miyanishi et al., 2007; Park et al., 2007) and PS-binding glycoprotein lactadherin (Dasgupta et al., 2008) . Role of PS exposure is well established in the anemia associated with genetic or pathologic disease states, but its implications in chemical-induced anemia have not been fully understood. Recently, Lang et al. (2008) suggested the possible contribution of erythrocyte PS exposure and eryptosis, apoptotic features in erythrocyte in lead-induced anemia through in vitro experiments. However, the clear demonstration of their in vitro results in relevant in vivo model has not been provided yet. Our study showing that ␤L could induce anemia through increased PS exposure and erythrophagocytosis in vivo provides an important piece of evidence for the contribution of PS exposure in chemicalinduced anemia.
Recently, Bowman et al. (2005a) reported that 5-hydroxyprimaquine (5-HPQ), a metabolite of primaquine could enhance the clearance of rat erythrocyte by splenic macrophage. They found that 5-HPQ-induced ROS could generate hemoglobin thyl radical and adduct with membrane protein and suggested that oxidative damage of membrane cytoskeleton and CD47 might increase erythrophagocytosis in rat (Bowman et al., 2005b) . However, they could not find PS exposure after 5-HPQ treatment in erythrocytes. The discrepancy from our findings might be explained by the difference in species, i.e., between rat and human in our study or the chemicals used. We confirmed that ␤L could induce PS exposure significantly in rat erythrocytes (data not shown), suggesting that the difference in chemicals is the most probable reason underlying the discrepancy from our study.
In conclusion, we demonstrated that ␤L-induced anemia might be mediated by PS exposure and increased erythrophagocytosis by spleen through in vitro and in vivo models. Most importantly, this study has provided an important clue for the role of PS exposure and erythrophagocytosis in the drug-induced anemia.
